Tetraphase Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Tetraphase Pharmaceuticals

Access the complete profile.

Tetraphase Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 541711 Research & Development in Biotechnology
Address	201 Jones Rd Suite 400 Waltham, MA 02451

Note: Revenues for privately held companies are statistical evaluations.


Tetraphase Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Tetraphase Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Tetraphase Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Tetraphase Pharmaceuticals Annual Revenue and Growth Rate

Tetraphase Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Tetraphase Pharmaceuticals's revenues are gauged from an analysis of company filings.

Tetraphase Pharmaceuticals's Income Statement (based on Industry Averages)

Tetraphase Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Tetraphase Pharmaceuticals is developing and marketing. Tetraphase Pharmaceuticals doesn't have any recent trademark applications, indicating Tetraphase Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
XERAVA Pharmaceuticals, namely, antibiotics indicated for the treatment of infections; the aforementioned not for the treatment of rheumatoid arthritis or psoriasis	02/02/2018
XRAVA Pharmaceutical preparations, namely, antibiotics	02/02/2018
XYRAVIO Pharmaceutical preparations, namely, antibiotics; all of the foregoing excluding pharmaceutical preparations and substances for the treatment and/or management of, the central nervous system, sleep disorders, cognitive disorders, fibromyalgia, insomnia, narcolepsy, and neurological or psychiatric diseases or disorders	12/11/2015

See all trademarks and details in the Full Report.

Market Share of Tetraphase Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Tetraphase Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Tetraphase Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REPLIGEN	Waltham, Massachusetts,united States, MA	100
APELLIS PHARMACEUTICALS	Waltham, MA	67
CUBIST PHARMACEUTICALS	Lexington, MA	59
BIOVERATIV U.S. LLC.	Waltham, MA	58
ABCAM	Waltham, MA	29
KARYOPHARM THERAPEUTICS	Newton, MA	25

Other Companies at 201 Jones Rd, Waltham MA

Company	Headquarters	Revenue ($ MM)
J C CANNISTRARO	Waltham, MA	100
AVEDRO	Waltham, MA	43
FONTAINE INSURANCE & FINANCIAL	Waltham, MA	2
TELERIK	Waltham, MA	0

Future Competition: Tetraphase Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Tetraphase Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)